<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Sixty-six samples of CSF from 66 patients with a variety of diseases, including <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, <z:hpo ids='HP_0100026'>arteriovenous malformations</z:hpo>, <z:hpo ids='HP_0002617'>aneurysms</z:hpo>, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e>, and lumbar <z:hpo ids='HP_0003418'>back pain</z:hpo>, were studied with 1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy at 360 MHz </plain></SENT>
<SENT sid="1" pm="."><plain>1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy offers a simple means to obtain fast information about different metabolites simultaneously </plain></SENT>
<SENT sid="2" pm="."><plain>As compared with the control group, which consisted of 19 CSF samples from the same group of 66 patients, but from individuals who had no abnormal findings on neurologic examination, common clinicochemical tests, or neuroradiologic studies, our preliminary results suggest that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and <z:mp ids='MP_0001914'>hemorrhages</z:mp> may be differentiated by 1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> peak intensities relative to <z:chebi fb="4" ids="24996">lactate</z:chebi> peak intensity were used as variables in a statistical analysis to determine the significance of individual resonance intensities in predicting <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> abnormalities </plain></SENT>
<SENT sid="4" pm="."><plain>The most important factors for diagnosis were analyzed by means of a multivariate general linear hypothesis and a principal component method </plain></SENT>
<SENT sid="5" pm="."><plain>The most important factors for predicting <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> abnormalities in the studied diseases were <z:chebi fb="0" ids="16737">creatinine</z:chebi>, <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="2" ids="16919">creatine</z:chebi>, <z:chebi fb="2" ids="50744">citrate</z:chebi>, protein content, glutamine, amount of cells, and valine </plain></SENT>
<SENT sid="6" pm="."><plain>By using this model for discriminant analysis, we could predict <z:mp ids='MP_0001914'>hemorrhages</z:mp> correctly in 88% of cases and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in 75% of cases </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> samples of controls were determined correctly </plain></SENT>
<SENT sid="8" pm="."><plain>In cases of <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e>, different signals were observed, which may lead to further characterization of such lesions </plain></SENT>
<SENT sid="9" pm="."><plain>1H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectroscopy may offer a simple means for further characterizing <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> lesions </plain></SENT>
<SENT sid="10" pm="."><plain>However, this needs confirmation by a prospective study, which would include a larger patient population with different diseases </plain></SENT>
</text></document>